Table 1 Summary of therapeutic effect miR-520d-5p/Atelocollagen complex in a xenografted model
Cancer cells | Tumor suppressive effect in subcutaneous model (n = 8 for each) 10 week, average% | Therapeutic effect in peritoneal model (n = 8 for each) % (effective/total) | Metastasis suppressive effect in caudal vein model (n = 8 for each) % (effective/total) |
|---|---|---|---|
HLF (undifferentiated hepatoma) | 92.7 | 75.0 (6/8) | 100 (8/8) |
HMV-1 (undifferentiated melanoma) | 85.9 | 87.5 (7/8) | 100 (8/8) |